Therapeutics: Erdafitinib for bladder cancer

06:43 EDT 17 May 2019 | Manufacturing Chemist

Urothelial cancer, which most often occurs in the bladder, is one of the more common types of cancer, but the prognosis is not good: the relative five-year survival rate for Stage IV disease is just 5%

Original Article: Therapeutics: Erdafitinib for bladder cancer


More From BioPortfolio on "Therapeutics: Erdafitinib for bladder cancer"

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Bladder Cancer
Non-invasive bladder cancer is a cancer that is only in the inner lining of the bladder. Invasive bladder cancer is cancer that has spread into the deeper walls of the bladder. When the cancer has spread outside the bladder to other parts of the body, th...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...